PEDICA, FEDERICA
 Distribuzione geografica
Continente #
EU - Europa 2.560
AS - Asia 2.384
NA - Nord America 1.889
SA - Sud America 383
Continente sconosciuto - Info sul continente non disponibili 202
AF - Africa 49
OC - Oceania 3
Totale 7.470
Nazione #
US - Stati Uniti d'America 1.746
RU - Federazione Russa 1.409
SG - Singapore 929
CN - Cina 732
IT - Italia 521
BR - Brasile 309
HK - Hong Kong 232
VN - Vietnam 181
DE - Germania 131
FR - Francia 113
BD - Bangladesh 95
GB - Regno Unito 88
CA - Canada 71
IN - India 63
FI - Finlandia 62
SE - Svezia 55
NL - Olanda 42
MX - Messico 41
PL - Polonia 32
AT - Austria 31
AR - Argentina 26
JP - Giappone 26
ES - Italia 17
TR - Turchia 17
IQ - Iraq 15
ZA - Sudafrica 15
EC - Ecuador 12
ID - Indonesia 11
IE - Irlanda 10
JM - Giamaica 9
LT - Lituania 9
PK - Pakistan 9
MY - Malesia 8
UZ - Uzbekistan 8
VE - Venezuela 8
BE - Belgio 7
CH - Svizzera 7
CO - Colombia 7
TT - Trinidad e Tobago 7
MA - Marocco 6
PY - Paraguay 6
AE - Emirati Arabi Uniti 5
DZ - Algeria 5
IR - Iran 5
KE - Kenya 5
TH - Thailandia 5
TN - Tunisia 5
TW - Taiwan 5
UA - Ucraina 5
UY - Uruguay 5
AO - Angola 4
CL - Cile 4
CR - Costa Rica 4
DK - Danimarca 4
NI - Nicaragua 4
NP - Nepal 4
PE - Perù 4
PH - Filippine 4
PS - Palestinian Territory 4
SA - Arabia Saudita 4
AL - Albania 3
AU - Australia 3
GH - Ghana 3
KR - Corea 3
AZ - Azerbaigian 2
BG - Bulgaria 2
BH - Bahrain 2
CY - Cipro 2
HN - Honduras 2
IL - Israele 2
KH - Cambogia 2
KZ - Kazakistan 2
LB - Libano 2
MD - Moldavia 2
OM - Oman 2
RO - Romania 2
RS - Serbia 2
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BS - Bahamas 1
BW - Botswana 1
BY - Bielorussia 1
EG - Egitto 1
EU - Europa 1
GE - Georgia 1
GT - Guatemala 1
GY - Guiana 1
JO - Giordania 1
LC - Santa Lucia 1
MK - Macedonia 1
MU - Mauritius 1
PT - Portogallo 1
RW - Ruanda 1
SC - Seychelles 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
SN - Senegal 1
SV - El Salvador 1
Totale 7.269
Città #
Singapore 606
Ashburn 268
Moscow 266
San Jose 265
Hong Kong 225
Dallas 157
Milan 134
Beijing 131
Shanghai 124
Council Bluffs 104
Hefei 81
Lauterbourg 72
Los Angeles 71
New York 71
Ho Chi Minh City 61
Santa Clara 59
Rome 46
Boardman 43
Hanoi 37
Munich 36
São Paulo 31
Orem 30
Warsaw 28
Helsinki 27
London 27
Nuremberg 26
Montreal 24
Frankfurt am Main 22
Lappeenranta 22
Brooklyn 21
Houston 20
Mexico City 19
Tokyo 19
Vienna 19
Denver 17
Guangzhou 17
Toronto 17
Atlanta 16
Chennai 16
Chicago 14
Johannesburg 13
Turku 13
Boston 12
Seattle 12
Stockholm 12
Amsterdam 11
Ankara 11
Falkenstein 11
Genoa 11
Lawrence 11
Philadelphia 11
Poplar 11
Princeton 11
Romagnano Sesia 11
Bologna 10
Cesano Boscone 9
Da Nang 9
Dublin 9
San Francisco 9
Baghdad 8
Belo Horizonte 8
Monza 8
Phoenix 8
Tashkent 8
Bexley 7
Brussels 7
Cagliari 7
City of London 7
Dhaka 7
Florence 7
Haiphong 7
Mugnano di Napoli 7
Mumbai 7
Rio de Janeiro 7
Shenzhen 7
Trento 7
Xi'an 7
Bergamo 6
Buffalo 6
Guarulhos 6
Jiaxing 6
Kingston 6
Kolkata 6
Manchester 6
Paris 6
Parma 6
Turin 6
Bari 5
Changsha 5
Gatchina 5
Kuala Lumpur 5
Nairobi 5
New Delhi 5
Ottawa 5
Porto Alegre 5
Rho 5
Washington 5
Asunción 4
Baltimore 4
Barnet 4
Totale 3.749
Nome #
In vivo macrophage engineering reshapes the tumor microenvironment leading to eradication of liver metastases 203
A complex case of severe acute hepatitis with cholestasis in a genetically predisposed woman: Could curcumin be the trigger? 188
Revealing and harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cells 184
Pathology and molecular pathology of cholangiocarcinoma 157
Quantitative measurement of 18F-FDG PET/CT uptake reflects the expansion of circulating plasmablasts in IgG4-related disease 137
Case report: EML4::NTRK3 gene fusion in a patient with metastatic lung adenocarcinoma successfully treated with entrectinib 136
Acute and Chronic Manifestations of Sympathetic Ophthalmia on Multimodal Imaging 130
Fat-to-blood recirculation of partially dysfunctional PD-1+CD4 Tconv cells is associated with dysglycemia in human obesity 126
Comparing Liver Venous Deprivation and Portal Vein Embolization for Perihilar Cholangiocarcinoma: Is It Time to Shift the Focus to Hepatic Functional Reserve Rather than Hypertrophy? 124
Clinical Outcomes After Progression on First-Line Therapies in IDH1 Mutated Versus Wild-Type Intrahepatic Cholangiocarcinoma Patients 123
Combined hepatocellular-cholangiocarcinoma: morpho-molecular updates and considerations 117
Real-World Data on Ivosidenib in Patients with Previously Treated Isocitrate Dehydrogenase 1-Mutated Intrahepatic Cholangiocarcinomas: An Early Exploratory Analysis 114
La misurazione quantitativa dell’uptake di 18F-FDG in TC/PET riflette l’espansione dei plasmablasti circolanti nella malattia IgG4 correlata 113
Germline testing and genetic counseling in biliary tract cancer: an operative proposal to improve the state of art 111
Atezolizumab plus bevacizumab versus lenvatinib or sorafenib in non-viral unresectable hepatocellular carcinoma: an international propensity score matching analysis 111
Workflow for high-dimensional flow cytometry analysis of T cells from tumor metastases 108
Harnessing CD39 for the Treatment of Colorectal Cancer and Liver Metastases by Engineered T Cells 107
Cervix neuroendocrine carcinoma presenting with severe hypokalemia and Cushing’s syndrome 106
Radial and longitudinal margins in surgery of perihilar cholangiocarcinoma: When R1 definition is associated with different prognosis 105
Association of IgG4-related disease and systemic rheumatic disorders 105
Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab–bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study 104
Gene-Based Immune Reprogramming Overcomes the Immunosuppressive Microenvironment of Liver Metastases and Enables Protective T Cell Responses 103
Next-generation sequencing analysis of cholangiocarcinoma identifies distinct IDH1-mutated clusters 103
Real-Life Clinical Data of Lenvatinib versus Sorafenib for Unresectable Hepatocellular Carcinoma in Italy 103
Harnessing CD39 for the treatment of colorectal cancer and liver metastases by engineered T cells 103
CD4+ T cells license Kupffer cells to reverse CD8+ T cell dysfunction induced by hepatocellular priming 100
HARNESSING CD39 FOR THE TREATMENT OF COLORECTAL CANCER AND LIVER METASTASES BY ENGINEERED T CELLS 97
A Re-Emerging Marker for Prognosis in Hepatocellular Carcinoma: The Add-Value of FISHing c-myc Gene for Early Relapse 97
Survival Outcomes of Durvalumab in Combination with Cisplatin and Gemcitabine in Advanced Biliary Tract Cancer: Real-World Results from a Single Italian Institution 95
Defining and predicting textbook outcomes for perihilar cholangiocarcinoma: analysis of factors improving achievement of desired postoperative outcomes 95
New molecular mechanisms in cholangiocarcinoma: signals triggering interleukin-6 production in tumor cells and KRAS co-opted epigenetic mediators driving metabolic reprogramming 94
Clinical relevance of biomarkers in cholangiocarcinoma: critical revision and future directions 94
N-Glycosylation Inhibition Hinders Immunosuppressive Activity of Tumor Microenvironment Cells and Improves CAR T Cell Efficacy 94
Validation of the easy-to-use lenvatinib prognostic index to predict prognosis in advanced hepatocellular carcinoma patients treated with lenvatinib 90
Common features between neoplastic and preneoplastic lesions of the biliary tract and the pancreas 90
Cathepsin-k as a diagnostic marker in the identification of micro-granulomas in Crohn's disease 90
Intrahepatic cholangiocarcinoma development in a patient with a novel BAP1 germline mutation and low exposure to asbestos 88
HCC in metabolic syndrome: current concepts and future directions 88
Minimally Invasive Approach Provides Oncological Benefit in Patients with High Risk of Very Early Recurrence (VER) After Surgery for Intrahepatic Cholangiocarcinoma (iCCA) 88
Cholangiocarcinoma: new perspectives for new horizons 88
The pathogenic role of epithelial and endothelial cells in early-phase COVID-19 pneumonia: victims and partners in crime 87
The real life of precision medicine in biliary tract cancers: a tertiary referral centre experience 87
Covid-19 Interstitial Pneumonia: Histological and Immunohistochemical Features on Cryobiopsies 86
Corrigendum to ‘Gene mutational profile of BRCAness and clinical implication in predicting response to platinum-based chemotherapy in patients with intrahepatic cholangiocarcinoma’ [Euro J Cancer 171 (2022) 232–241, (S0959804922002829), (10.1016/j.ejca.2022.05.004)] 85
The oncologic burden of residual disease in incidental gallbladder cancer: An elastic net regression model to profile high-risk features 85
Synchronous Unicentric Castleman Disease and Inflammatory Hepatocellular Adenoma: a Case Report 85
IFNalpha by In Vivo-Engineered Macrophages Abates Liver Metastases and Triggers Counter Regulatory Responses Limiting Efficacy 83
Subcutaneous dirofilariosis in Italy: a diagnostic hypothesis to remind when the anamnesis is misleading 81
Clinical, radiological and pathological findings in patients with persistent lung disease following SARS-CoV-2 infection 79
Molecular profile and its clinical impact of IDH1 mutated versus IDH1 wild type intrahepatic cholangiocarcinoma 78
IFNalpha by in vivo-engineered macrophages abates liver metastases and triggers counter regulatory responses limiting efficacy 77
3D Models as a Tool to Assess the Anti-Tumor Efficacy of Therapeutic Antibodies: Advantages and Limitations 77
Repeated administration of the food additive E171 to mice results in accumulation in intestine and liver and promotes an inflammatory status 76
Same-session endoscopic diagnosis and symptom palliation in pancreato-biliary malignancies: Clinical impact of rapid on-site evaluation (ROSE) 75
Age influence on mice lung tissue response to Aspergillus fumigatus chronic exposure 73
Histological and serological features of acute liver injury after SARS-CoV-2 vaccination 72
Clinicopathological features of adenosquamous pancreatic cancer 71
Pure and mixed gallbladder neuroendocrine neoplasms: rare and orphan lesions 70
Mucinous cystic neoplasms of the liver: A clinicopathological study and comparison with intraductal papillary neoplasms of the bile duct 70
Late Breaking Abstract - Morphological and immunophenotypical features of lung tissue in early phase of COVID-19 69
Gene mutational profile of BRCAness and clinical implication in predicting response to platinum-based chemotherapy in patients with intrahepatic cholangiocarcinoma 68
Distinctive features of hepatocellular carcinoma in non-alcoholic fatty liver disease 66
PDX-1 (Pancreatic/Duodenal Homeobox-1 Protein 1) 63
Epithelial to mesenchymal transition-related proteins ZEB1, β-catenin, and β-tubulin-III in idiopathic pulmonary fibrosis. 63
Peribiliary glands pathology in a large series of end-stage alcohol-related liver disease 62
Lymphangiogenesis in Crohn's disease: An immunohistochemical study using monoclonal antibody D2-40 61
Hydroxyapatite/collagen composite is a reliable material for malar augmentation 59
IgG4-related autoimmune liver disease 58
MERTK AND THE RESOLUTION OF INFLAMMATION IN IGG4-RELATED DISEASE 58
Mer tyrosine kinase as a possible link between resolution of inflammation and tissue fibrosis in IgG4-related disease 58
Preliminary results of the influence of the in vivo use of a lymphatic dye (Patent Blue V) in the surgical treatment of Crohn's disease 58
Endocrine neoplasms of the pancreas: pathologic and genetic features. 57
Heterogeneity of response and immune system activity during treatment with nivolumab in hepatocellular carcinoma: Results from a single-institution retrospective analysis 57
Total portal vein replacement with peritoneal interposition graft during Whipple’s procedure for extrahepatic cholangiocarcinoma: a technical report 56
Paraoxonase-1 status in patients with hereditary hemochromatosis 55
Programmed death 1 (PD-1) and its ligand (PD-L1) as a new frontier in cancer Immunotherapy and challenges for the Pathologist: State of the art 51
Laparoscopic Surgery for Intrahepatic Cholangiocarcinoma: A Focus on Oncological Outcomes 51
Massive retinal gliosis in a young woman with congenital toxoplasmosis 51
Toxicity profile of adjuvant hypofractionated Image-Guided Radiotherapy in biliary tract carcinoma 48
Outcome of adjuvant hypofractionated radiotherapy concomitant to chemotherapy in bile duct carcinoma 48
Does intrahepatic cholangiocarcinoma have better prognosis compared to perihilar cholangiocarcinoma? 44
Radial and Longitudinal Margins in Surgery of Perihilar Cholangiocarcinoma: When R1 Definition Is Associated with Different Prognosis 43
Surgery for hepatocellular carcinoma and intrahepatic cholangiocarcinoma: milestone changes in the last two decades potentially affecting current guidelines 43
Intrahepatic bile duct mixed adenoneuroendocrine carcinoma: A case report and review of the literature 42
Next-generation histopathologic diagnosis: A lesson from a hepatic carcinosarcoma 39
A viable human lung cancer tissue collection (LCTC) to accelerate translational research 21
How to approach indeterminate biliary stenosis 6
Edoxaban-Induced Vanishing Bile Duct Syndrome: A Case Report With Review of the Literature 5
Comprehensive genetic analysis in biliary tract cancer: a prospective single-center experience 4
Totale 7.470
Categoria #
all - tutte 32.960
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.960


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202214 0 0 2 3 0 2 2 1 1 2 0 1
2022/202382 25 16 9 0 1 15 5 4 7 0 0 0
2023/2024449 11 65 50 41 20 33 19 42 4 18 64 82
2024/20251.507 169 41 63 69 85 117 260 177 170 86 112 158
2025/20265.046 356 308 221 628 603 183 452 386 1.302 255 150 202
2026/2027365 182 183 0 0 0 0 0 0 0 0 0 0
Totale 7.470